OFFICIAL PUBLICATION OF

by its subsidiary APPco

New therapies for hep C listed

AJP Staff 18/04/2016

New therapies have been PBS listed for the treatment of genotype 1 chronic hepatitis C virus. AbbVie Australia today announced that Viekira Pak (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and Viekira Pak-RBV (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets with ribavirin) will be listed on the PBS from 1st May 2016. The two therapies are approved for use

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Sigma/CWH merger to change pharmacy

Absolutely pathetic excuse by Wesfarmers. They're an ASX heavyweight and they're afraid of a smaller company? The lack of innovation…

Morbidly Obese John

Sigma/CWH merger to change pharmacy

You seen the average wage working for these toxic workplaces in USA? Our toxic workplaces have a lot to catch…

Philip Smith

Sigma/CWH merger to change pharmacy

Anthony and economist that drafted this post for you , I attempted to post a reply multiple times with supportive…

Michael Post

ACCC announces Chemist Warehouse/Sigma merger decision

I don't have time to reply to all your comments in the truly meaningful way that they deserve. Sorry about…

Siya Etzebeth

New therapies for hep C listed

Previous New chemo listing in indolent Non-Hodgkin’s Lymphoma

Next Cardiac rehabilitation programs needed

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous New chemo listing in indolent Non-Hodgkin’s Lymphoma

Next Cardiac rehabilitation programs needed

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.